🏛️ Verified NIH Record • Updated 2026-06-08
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight (NCT07357415)
A Phase 3b Study to Investigate the Efficacy and Safety of Different Retatrutide Dose Escalation Schemes in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Controlled, Double-Blind Trial
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Eli Lilly and Company
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to investigate the efficacy and safety of different retatrutide dose escalation schemes in participants without type 2 diabetes who have obesity or overweight. Participation in the study will last about 113 weeks.
Who can join: Review the eligibility criteria below.
Location: Arizona Research Center — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (35 Sites)
Showing the first 25 of 35 sites.
- Arizona Research Center — Phoenix, Arizona
- Care Access - Huntington Beach — Huntington Beach, California
- Los Angeles Institute for Metabolic Research — Los Angeles, California
- New Horizon Research Center — Miami, Florida
- Encore Medical Research - Weston — Weston, Florida
- Pacific Diabetes & Endocrine Center — Honolulu, Hawaii
- Monroe Biomedical Research - Louisville — Louisville, Kentucky
- Brigham and Women's Hospital Diabetes Program — Boston, Massachusetts
- Great Lakes Research Group, Inc. — Bay City, Michigan
- NYC Research INC — Long Island City, New York
- Weill Cornell Medical College — New York, New York
- Care Access - Raleigh — Raleigh, North Carolina
- New Phase Research and Development — Knoxville, Tennessee
- Velocity Clinical Research, Dallas — Dallas, Texas
- Cedar Health Research - Texas Native Health — Dallas, Texas
- Cedar Health Research — Dallas, Texas
- Cedar Health Research - Fort Worth — Fort Worth, Texas
- Advanced Research Institute — Ogden, Utah
- Dominion Medical Associates, Inc. — Richmond, Virginia
- CAMC Institute for Academic Medicine — Charleston, West Virginia
- Cicemo Srl — Buenos Aires,
- CARDIAMET Investigaciones Médicas — Buenos Aires,
- Stat Research S.A. — Buenos Aires,
- Centro de Investigaciones Metabólicas (CINME) — Buenos Aires,
- Centro Médico Viamonte — Buenos Aires,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity
- Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools — Tampa, Florida
- SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity — Tucson, Arizona
- Piloting a Patient Navigator Program for Weight Loss — Philadelphia, Pennsylvania
- Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2) — Mesa, Arizona
- Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects — Orlando, Florida
- Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans — Pittsburgh, Pennsylvania
Explore by condition: All Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.